BioSig Technologies Inc. (NASDAQ: BSGM), a Westport-based medical technology company focused on intracardiac signal visualization, has named Frederick Hrkac to the new role of executive vice president.
Since April 2022, Hrkac served on the BioSig board of directors and as chairman of its nominating and corporate governance committee. As a result of his appointment, Hrkac was replaced by board director James Klein as a member and chairman of the nominating and corporate governance committee.
Hrkac has more than three decades in the medical device industry. He was previously co-founder and managing partner of Access Strategy Partners Inc. and senior vice president of corportate development at Biosensors International Group Ltd.
“I am thrilled with the opportunity to bring BioSig’s groundbreaking technology into the hands of electrophysiologists with a strategy similar to my work 20 years ago in introducing novel cardiac navigational technology that shaped the way atrial fibrillation is treated globally,” said Hrkac. “I look forward to working closely with the outstanding leadership team at BioSig to spur PURE EP Platform adoption in multiple new geographic markets and drive multiple avenues of potential value creation.”
